Koyfin Home > Directory > Health Care > American Renal Associates > EV / EBITDA (ltm)

American Renal Associates EV / EBITDA (ltm) Chart (ARA)

American Renal Associates annual/quarterly EV / EBITDA (ltm) from 2016 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • American Renal Associates EV / EBITDA (ltm) for the quarter ending December 12, 2020 was 8.03 a 0.00% decrease of 0.00 year over year
  • American Renal Associates EV / EBITDA (ltm) for the last 12 months ending December 12, 2020 was 8.03 a 0.00% decrease of 0.00 year over year
  • American Renal Associates Annual EV / EBITDA (ltm) for 2020 was 8.03 a 0.08% increase of 0.01 from 2019
  • American Renal Associates Annual EV / EBITDA (ltm) for 2020 was 8.02 a -0.03% decrease of 0.00 from 2019
  • American Renal Associates Annual EV / EBITDA (ltm) for 2020 was 8.02 a -0.05% decrease of 0.00 from 2019
Other Valuation Metrics:
  • American Renal Associates Market Cap for the quarter ending March 03, 2018 was $605m a 4.42% increase of 27m year over year
  • American Renal Associates Enterprise Value for the quarter ending March 03, 2018 was $1,411m a 2.67% increase of 38m year over year
View Chart On Koyfin

Quarterly ARA EV / EBITDA (ltm) Data

12/20208.03
11/20208.02
11/20208.02
11/20208.03
11/20208.03
11/20208.02
11/20208.02
11/20208.02
11/20208.02
11/20208.02

Annual ARA EV / EBITDA (ltm) Data

20208.03
20208.02
20208.02
20208.03
20208.03
20208.02
20208.02
20208.02
20208.02
20208.02